Skip to Main Content

Paper Details

Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.
JAMA Oncol
5
2023
ATM, Aggressive Prostate Cancer, BARD1, BRCA2, DNA repair, GEN1, Gene Panel, Germline gene, MRE11A, MSH2, NBN, PCa, PCa death, Participants, RAD51D, SLX4, T3, TP53, XRCC2, advanced prostate cancer, cancer, cancer susceptibility genes, candidate genes, men, metastatic PCa, patients
Author NameAffiliation
Burcu F DarstCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California
Burcu F DarstFred Hutchinson Cancer Center
Burcu F DarstCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California
Burcu F DarstFred Hutchinson Cancer Center
Tokhir DadaevThe Institute of Cancer Research
Loreall PoolerCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Sonja I BerndtNational Cancer Institute, National Institutes of Health
Demetrius AlbanesNational Cancer Institute, National Institutes of Health
Stephanie J WeinsteinNational Cancer Institute, National Institutes of Health
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Roger L Milne
Roger L MilneUniversity of Melbourne
Roger L MilneSchool of Clinical Sciences at Monash Health, Monash University
Mark M PomerantzDana-Farber Cancer Institute
Mark M PomerantzDana-Farber Cancer Institute
Ruth C TravisUniversity of Oxford
Timothy J KeyUniversity of Oxford
Lorelei A MucciHarvard T. H. Chan School of Public Health
Kurt N HetrickCenter for Inherited Disease Research, Johns Hopkins School of Medicine
Kimberly F DohenyCenter for Inherited Disease Research, Johns Hopkins School of Medicine
Douglas F EastonThe Institute of Cancer Research
Douglas F EastonRoyal Marsden NHS Foundation Trust
Fredrik WiklundKarolinska Institute
David V ContiCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California
Zsofia Kote-JaraiThe Institute of Cancer Research
Christopher A HaimanCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California
Christopher A HaimanCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California
  • 1 - 32

Datasets